Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CLINICA 100 TOP 10: Abbott Labs

This article was originally published in Clinica

Executive Summary

Abbott Labs has moved up one position from last year to No 8 in our Clinica 100 list*. It remains at No 4 in both the IVD and Cardiology lists. Abbott has not made any big M&A deals in 2014/2015, looking instead to build its cardiovascular business with promising technologies that gives it access to fast-growing emerging segments. In 2014, it moved into the electrophysiology space for the first time with the acquisition of ablation mapping specialist Topera Medical. It also secured the rights to buy at a later date Advanced Cardiac Therapeutics, which is sdeveloping an irrigated radiofrequency ablation catheter technology.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst